ADH1A and breast carcinoma: Analysis of the TCGA-BRCA cohort data indicates a significant reduction in ADH1A mRNA expression levels across breast cancers with varying degrees of invasiveness (Fig. 3A), with the most pronounced decrease observed in TNBC (Fig. 3B).